Notably, inhibiting ERAP2 through knockdown techniques not only suppressed tumor growth but also augmented the efficacy of gemcitabine, frontline chemotherapy for pancreatic cancer, inhibiting cancer cell proliferation, migration, and invasion. The gene discussed is ERAP2; the disease is cancer.